New York, Apr 29th, 2019 - Creative Bioarray, an innovative biotechnology company focuses on developing unique technologies that provide global scientists with high quality products and satisfactory services, recently announces the launch of its ADME and Pharmacokinetic Services, which can help predict the bioavailability and bioactivity of a drug, as well as whether it can reach its intended target and confer a therapeutic effect, thereby promoting the drug developing process.
Drug discovery is a high-risk, high-cost, but high-return business. In drug discovery and development, the assessment of drug metabolism and early optimization of drug ADME properties are especially crucial. Without proper early assessment, many resources may be invested and wasted in candidate products that were subsequently proved to have an unacceptable ADME profile at a later evaluation. As a powerful and useful tool for early drug discovery, high-throughput screening (HTS) is widely used to avoid unnecessary losses, we have established several reliable in vitro ADME models and provides industrial high-throughput ADME screening and analysis services, which can also be modified and customized to meet specific requirements for project research settings.
Besides, drug safety and efficacy also is getting more attention among researchers, as the drug is eliminated by excretion or metabolism to produce one or more active or inactive metabolites after entering the human body, therefore, the metabolic rate and biological activity of the metabolites produced during the elimination process directly affect the retention time of the drug in the body. All of which makes it important to understand the metabolic pathways of drugs in the early stages of drug development to better predict drug toxicity or side effects, drug-drug interactions, and to obtain information that will help shape drug delivery strategies. Creative Bioarray involves the ability to offer a variety of flexible and integrated services for drug discovery with expertise and comprehensive knowledge in drug development.
In order to assess drug permeability and predict drug absorption and distribution, Creative Bioarray also offers a number of in vitro permeability and transporter assays. And many in vitro cell-based or cell-free methods are supported, including Caco-2 permeability assay, MDCK permeability assay as well as PAMPA.
‘Our company is equipped with experienced experts in the field of drug development. We are committed to providing our customers with comprehensive testing and high-quality data to help our customers achieve a great drug screening and optimization experience.’ said Hannah Cole, the marketing director of Creative Bioarray, ‘we can also customize the service to satisfy specific purpose’
About Creative Bioarray
Founded in 2005, Creative Bioarray provides customers with high-quality biotechnology products and services to facilitate the investigation of life science researches. As a well-recognized industry leader, we always devote to help solve complex analytical challenges and increase laboratory productivity with in-house professionals and more than 10 years of experience.
Media Contact
Company Name: Creative Bioarray
Contact Person: Hannah Cole
Email:Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road Shirley
City: Long Island City
State: New York
Country: United States
Website: http://www.creative-bioarray.com
